| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |